C2.3 Applying genetic test results in clinical practice to benefit youth
Tracks
Track 2
| Tuesday, June 11, 2024 |
| 10:40 AM - 10:50 AM |
| 210 |
Overview
Presented By: Dr. Anne Bassett
Details
By the end of this session, participants will be able to:
1. Describe 3 neuropsychiatric conditions associated with a 22q11.2 microdeletion that can present in children and youth.
2. Identify 3 advantages for individuals newly diagnosed with a 22q11.2 microdeletion.
3. Describe how advances in molecular understanding could improve clinical care of patients and their families.
Speaker
Dr. Anne Bassett
Professor
U Of Toronto
C2 - Predicting Clinical Outcomes and Improving Drug Therapy
